Tianjin Chase Sun Pharmaceutical Co., Ltd. Class A

Tianjin Chase Sun Pharmaceutical Co., Ltd. Class A

SSZSE:300026
3.01
CNY
-0.04
(-1.31%)
9.76BMarket Cap

Total Valuation

CNY

As of September 30, 2026, Tianjin Chase Sun Pharmaceutical Co., Ltd. Class A carries a market capitalization of 9.76B, placing it among publicly traded companies globally. Its enterprise value stands at 8.54B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap9.76B
Enterprise Value8.54B

Share Statistics

As of September 30, 2026, Tianjin Chase Sun Pharmaceutical Co., Ltd. Class A has 3.00B shares outstanding.

Shares Outstanding3.00B

Valuation Ratios

These figures are as of September 30, 2026.

PB Ratio1.14
P/TBV Ratio1.33

Financial Position

As of September 30, 2026, Tianjin Chase Sun Pharmaceutical Co., Ltd. Class A maintains a current ratio of 4.98, meaning it holds 5.0x the short-term assets needed to cover near-term liabilities.

Current Ratio4.98
Quick Ratio1.51
Debt / Equity4.01

Financial Efficiency

These figures cover the twelve months ended September 30, 2026.

Employee Count4,852.00

Taxes

CNY

Over the twelve months ended September 30, 2026, Tianjin Chase Sun Pharmaceutical Co., Ltd. Class A recorded 30.60M in income tax expense.

Income Tax30.60M

Stock Price Statistics

CNY

As of the close on November 17, 2026, Tianjin Chase Sun Pharmaceutical Co., Ltd. Class A's stock has declined approximately 23.02% over the past 52 weeks. The 50-day moving average sits at 3.21, while the 200-day moving average is 3.36.

52-Week Price Change-23.02%
50-Day Moving Average3.21
200-Day Moving Average3.36

Balance Sheet

CNY

As of September 30, 2026, Tianjin Chase Sun Pharmaceutical Co., Ltd. Class A holds 1.70B in cash and equivalents against 348.17M in total debt, resulting in a net debt position of -1.53B. Total book value stands at 8.57B, with working capital of 4.47B providing operational flexibility.

Cash & Cash Equivalents1.70B
Total Debt348.17M
Net Debt-1.53B
Equity (Book Value)8.57B
Book Value Per Share2.85
Working Capital4.47B

Cash Flow

CNY

These figures cover the twelve months ended September 30, 2026.

Capital Expenditures-75.50M

Dividends & Yields

CNY

Over the twelve months ended September 30, 2026, Tianjin Chase Sun Pharmaceutical Co., Ltd. Class A paid dividends of 0.01 per share.

Dividend Per Share0.01

Stock Splits

Tianjin Chase Sun Pharmaceutical Co., Ltd. Class A's most recent stock split took place on October 26, 2016 with a 1:3 split ratio.

Last Split Date10/26/2016
Split Ratio1:3